People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SpringWorks Therapeutics, Inc. | — | Pharma | Series D+ | $125.0M | $4.4B | 2019 |
Peter L Keen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Peter L Keen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| CARL L. GORDON | 1 | 7 |
| Daniel S. Lynch | 1 | 6 |
| Stephen L Squinto | 1 | 1 |
| Jeffrey L Schwartz | 1 | 1 |
| Deval L Patrick | 1 | 1 |
| Saqib S. Islam | 1 | 1 |
| Michael S. Greco | 1 | 1 |
| Freda L Lewis-Hall | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.